BS
Bernhard Scheiner
Author with expertise in Advancements in Colorectal Cancer Research
Achievements
This user has not unlocked any achievements yet.
Key Stats
Upvotes received:
0
Publications:
4
(0% Open Access)
Cited by:
0
h-index:
0
/
i10-index:
0
Reputation
Biology
< 1%
Chemistry
< 1%
Economics
< 1%
Show more
How is this calculated?
Publications
0

OS-078-YI Hepatic decompensation as an aetiology-dependent determinant of mortality in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

Ciro Celsa et al.Jun 1, 2024
+51
C
G
C
0

THU-471-YI From randomised clinical trials to clinical practice: a systematic reviewand meta-analysis of real-word data on atezolizumab plus bevacizumab for advanced hepatocellular carcinoma

Giulia Manfredi et al.Jun 1, 2024
+20
C
C
G
0

THU-464 aMAP score predicts progression-free survival in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

Mathew Vithayathil et al.Jun 1, 2024
+36
C
A
M
0

OS-112-YI Outcome and management of patients with hepatocellular carcinoma who achieved complete response to immunotherapybased systemic therapy

Bernhard Scheiner et al.Jun 1, 2024
+49
L
B
B